• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾结石患者患慢性肾脏病和终末期肾病的风险。

Risk of chronic and end stage kidney disease in patients with nephrolithiasis.

作者信息

Shoag Jonathan, Halpern Joshua, Goldfarb David S, Eisner Brian H

机构信息

Department of Urology, Weill Cornell Medical College, New York, New York.

New York Harbor VA Healthcare System, New York, New York; NYU School of Medicine, New York, New York.

出版信息

J Urol. 2014 Nov;192(5):1440-5. doi: 10.1016/j.juro.2014.05.117. Epub 2014 Jun 11.

DOI:10.1016/j.juro.2014.05.117
PMID:24929140
Abstract

PURPOSE

We examine kidney stone disease as a potential risk factor for chronic kidney disease, end stage kidney disease and treatment with dialysis.

MATERIALS AND METHODS

The NHANES (National Health and Nutrition Examination Survey) 2007-2010 database was interrogated for patients with a history of kidney stones. Demographics and comorbid conditions including age, gender, body mass index, diabetes, hemoglobin A1c, hypertension, gout and smoking were also assessed. Multivariate analysis adjusting for patient demographics and comorbidities was performed to assess differences in the prevalence of chronic kidney disease and treatment with dialysis between the 2 groups. History of nephrolithiasis was assessed with the question, "Have you ever had kidney stones?" Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml/minute/1.73 m(2) and/or a urinary albumin-to-creatinine ratio greater than 30 mg/gm. Statistical calculations were performed using Stata® software with determinations of p values and 95% CI where appropriate.

RESULTS

The study included an analysis of 5,971 NHANES participants for whom data on chronic kidney disease and kidney stones were available, of whom 521 reported a history of kidney stones. On multivariate analysis a history of kidney stones was associated with chronic kidney disease and treatment with dialysis (OR 1.50, 1.10-2.04, p = 0.013 and OR 2.37, 1.13-4.96, p = 0.025, respectively). This difference appeared to be driven by women, where a history of kidney stones was associated with a higher prevalence of chronic kidney disease (OR 1.76, 1.13-2.763, p = 0.016) and treatment with dialysis (OR 3.26, 1.48-7.16, p = 0.004). There was not a significant association between kidney stone history and chronic kidney disease or treatment with dialysis in men.

CONCLUSIONS

Kidney stone history is associated with an increased risk of chronic kidney disease and treatment with dialysis among women even after adjusting for comorbid conditions. Large scale prospective studies are needed to further characterize the relationship between nephrolithiasis and chronic kidney disease.

摘要

目的

我们研究肾结石病作为慢性肾脏病、终末期肾病及透析治疗潜在危险因素的情况。

材料与方法

对2007 - 2010年美国国家健康与营养检查调查(NHANES)数据库中患有肾结石病史的患者进行查询。还评估了人口统计学和合并症情况,包括年龄、性别、体重指数、糖尿病、糖化血红蛋白、高血压、痛风和吸烟情况。进行多变量分析以调整患者人口统计学和合并症因素,从而评估两组之间慢性肾脏病患病率及透析治疗情况的差异。通过询问“你是否曾患过肾结石?”来评估肾结石病史。慢性肾脏病定义为估算肾小球滤过率低于60毫升/分钟/1.73平方米和/或尿白蛋白与肌酐比值大于30毫克/克。使用Stata®软件进行统计计算,并在适当情况下确定p值和95%置信区间。

结果

该研究纳入了5971名有慢性肾脏病和肾结石数据的NHANES参与者,其中521人报告有肾结石病史。多变量分析显示,肾结石病史与慢性肾脏病及透析治疗相关(比值比分别为1.50,95%置信区间为1.10 - 2.04,p = 0.013;以及比值比为2.37,95%置信区间为1.13 - 4.96,p = 0.025)。这种差异似乎在女性中更为明显,肾结石病史与慢性肾脏病患病率较高相关(比值比为1.76,95%置信区间为1.13 - 2.763,p = 0.016)以及透析治疗相关(比值比为3.26,95%置信区间为1.48 - 7.16,p = 0.004)。在男性中,肾结石病史与慢性肾脏病或透析治疗之间无显著关联。

结论

即使在调整合并症因素后,肾结石病史在女性中仍与慢性肾脏病风险增加及透析治疗相关。需要大规模前瞻性研究来进一步明确肾结石病与慢性肾脏病之间的关系。

相似文献

1
Risk of chronic and end stage kidney disease in patients with nephrolithiasis.肾结石患者患慢性肾脏病和终末期肾病的风险。
J Urol. 2014 Nov;192(5):1440-5. doi: 10.1016/j.juro.2014.05.117. Epub 2014 Jun 11.
2
Relationship between C-reactive protein and kidney stone prevalence.C-反应蛋白与肾结石患病率的关系。
J Urol. 2014 Feb;191(2):372-5. doi: 10.1016/j.juro.2013.09.033. Epub 2013 Sep 23.
3
Kidney Stones and Risk of Narcotic Use.肾结石与麻醉药物使用风险。
J Urol. 2019 Jul;202(1):114-118. doi: 10.1097/JU.0000000000000197. Epub 2019 Jun 7.
4
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.代谢综合征特征与肾结石严重程度的相关性:来自日本全国尿路结石调查的结果。
Am J Kidney Dis. 2013 Jun;61(6):923-9. doi: 10.1053/j.ajkd.2012.12.028. Epub 2013 Feb 20.
5
Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III.有肾结石病史的成年人肾功能下降:一项对美国国家健康和营养检查调查(NHANES)III的研究。
Kidney Int. 2005 Feb;67(2):685-90. doi: 10.1111/j.1523-1755.2005.67128.x.
6
The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study.男性痛风与肾结石的关联:健康专业人员随访研究
Kidney Int. 2003 Sep;64(3):1022-6. doi: 10.1046/j.1523-1755.2003.t01-2-00171.x.
7
Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.饮食因素与男性新发肾结石风险:14年随访后的新见解
J Am Soc Nephrol. 2004 Dec;15(12):3225-32. doi: 10.1097/01.ASN.0000146012.44570.20.
8
Nephrolithiasis-related end stage renal disease.肾结石相关终末期肾病
Minerva Urol Nefrol. 2013 Jun;65(2):101-7.
9
Dietary zinc intake and kidney stone formation: evaluation of NHANES III.膳食锌摄入与肾结石形成:NHANES III 评估。
Am J Nephrol. 2012;36(6):549-53. doi: 10.1159/000345550. Epub 2012 Dec 4.
10
[Nephrolithiasis-induced ESRD: frequency, causes and prevention].[肾结石所致终末期肾病:发病率、病因及预防]
Nephrol Ther. 2005 Nov;1(5):301-10. doi: 10.1016/j.nephro.2005.08.001. Epub 2005 Oct 3.

引用本文的文献

1
Kidney stone disease: risk factors, pathophysiology and management.肾结石疾病:危险因素、病理生理学及管理
Nat Rev Nephrol. 2025 Aug 11. doi: 10.1038/s41581-025-00990-x.
2
Apoptosis, ferroptosis, necrosis, necroptosis and pyroptosis in the formation of calcium oxalate kidney stones.细胞凋亡、铁死亡、坏死、坏死性凋亡和焦亡在草酸钙肾结石形成中的作用
Urolithiasis. 2025 Aug 11;53(1):153. doi: 10.1007/s00240-025-01826-w.
3
Decoding coffee's chlorogenic acid: genetic-network pharmacology insights on kidney stones.解读咖啡中的绿原酸:关于肾结石的基因网络药理学见解
Urolithiasis. 2025 Jun 21;53(1):124. doi: 10.1007/s00240-025-01776-3.
4
Plasma Aldosterone Elevation in Hypertensive Patients and Association with Urinary Stone Formation: A Large-Scale Population Study from Northwest China.高血压患者血浆醛固酮升高与尿路结石形成的关联:一项来自中国西北的大规模人群研究
Clin Epidemiol. 2025 May 30;17:497-512. doi: 10.2147/CLEP.S522455. eCollection 2025.
5
Systematic review of pharmacological, complementary, and alternative therapies for the prevention of calcium oxalate stones.预防草酸钙结石的药物、补充和替代疗法的系统评价
Asian J Urol. 2025 Apr;12(2):169-188. doi: 10.1016/j.ajur.2024.04.006. Epub 2024 Jul 4.
6
Risk factors for readmission after ureteroscopy for stone disease: Modern single centre experience.输尿管镜治疗结石疾病后再入院的危险因素:现代单中心经验
BJUI Compass. 2025 Mar 23;6(3):e70007. doi: 10.1002/bco2.70007. eCollection 2025 Mar.
7
Enhancer Profiling Reveals a Protective Role of RXRα Against Calcium Oxalate-Induced Crystal Deposition and Kidney Injury.增强子分析揭示了RXRα对草酸钙诱导的晶体沉积和肾损伤的保护作用。
Adv Sci (Weinh). 2025 Jun;12(21):e2411735. doi: 10.1002/advs.202411735. Epub 2025 Mar 17.
8
Trends in the burden of urolithiasis in China: an analysis from the global burden of disease study 2021.中国尿石症负担趋势:来自《2021年全球疾病负担研究》的分析
Front Surg. 2025 Feb 18;12:1537706. doi: 10.3389/fsurg.2025.1537706. eCollection 2025.
9
An analysis of the burden of urolithiasis: differences between the global, China, India and the United States, with projections through 2050.尿石症负担分析:全球、中国、印度和美国之间的差异及到2050年的预测
Urolithiasis. 2025 Feb 15;53(1):32. doi: 10.1007/s00240-025-01695-3.
10
Association of tea consumption with all-cause/cardiovascular disease mortality in the chronic kidney disease population: an assessment of participation in the national cohort.慢性肾脏病患者中茶消费与全因/心血管疾病死亡率的关联:一项全国队列参与情况评估
Ren Fail. 2025 Dec;47(1):2449578. doi: 10.1080/0886022X.2025.2449578. Epub 2025 Jan 13.